SI-BONE Financial Statements
NASDAQ: SIBNHealth CareMedical/Dental InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
SI-BONE revenue and earnings
In fiscal 2025, SI-BONE generated $200.9 million in revenue, up 20.2% from fiscal 2024, its 8th consecutive year of revenue growth. SI-BONE reported a net loss of $18.9 million, compared with a loss of $30.9 million a year earlier. Gross margin was 79.6% (up from 79.0%) and operating margin -11.1%.
Diluted earnings per share came in at -$0.44. Over the last 5 fiscal years, SIBN's revenue has grown at a 22.3% compound annual rate.
Summary generated from market data by MetaCap's automated system. Methodology
SI-BONE income statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 200.93M | 167.18M | 138.89M | 106.41M | 90.15M | 73.39M | 67.30M | 55.38M | 47.98M |
| Revenue growth (YoY) | +20.19% | +20.37% | +30.52% | +18.03% | +22.84% | +9.04% | +21.53% | +15.42% | — |
| Cost of Revenue | 41.05M | 35.06M | 29.47M | 15.71M | 10.43M | 8.90M | 6.79M | 4.83M | 5.11M |
| Gross Profit | 159.88M | 132.12M | 109.42M | 90.70M | 79.72M | 64.48M | 60.51M | 50.55M | 42.87M |
| Operating Expenses | 182.21M | 167.37M | 156.35M | 150.31M | 131.39M | 103.05M | 96.51M | 62.51M | 60.22M |
| Research & Development | 17.45M | 16.56M | 15.03M | 13.63M | 12.44M | 9.46M | 7.28M | 5.38M | 5.51M |
| Selling, General & Admin | 164.76M | 150.81M | 141.32M | 136.69M | 118.95M | 93.59M | 89.23M | 57.14M | 54.71M |
| Operating Income | -22.33M | -35.25M | -46.93M | -59.61M | -51.67M | -38.57M | -36.00M | -11.96M | -17.35M |
| Interest Expense | 2.63M | 3.44M | 3.46M | 2.82M | 5.37M | 6.10M | 4.95M | 5.11M | 6.20M |
| Other Income (Expense) | -20.00K | -73.00K | 141.00K | -132.00K | 277.00K | -126.00K | -2.00K | -1.15M | 340.00K |
| Pretax Income | -19.09M | -31.08M | -43.49M | -61.40M | -57.03M | -43.70M | -38.40M | -17.45M | -23.04M |
| Income Tax | 0 | 0 | 0 | 0 | 0 | — | — | 0 | 0 |
| Net Income | -18.90M | -30.91M | -43.34M | -61.26M | -56.57M | -43.70M | -38.40M | -17.45M | -23.04M |
| Net Income growth (YoY) | — | — | — | — | — | — | — | — | — |
| EPS (Basic) | -0.44 | -0.75 | -1.13 | -1.79 | -1.71 | -1.50 | -1.55 | -2.20 | -6.65 |
| EPS (Diluted) | -0.44 | -0.75 | -1.13 | -1.79 | -1.71 | -1.50 | -1.55 | -2.20 | -6.65 |
| Shares Outstanding (Basic) | 42.96M | 41.47M | 38.43M | 34.20M | 33.15M | 29.06M | 24.71M | 7.95M | 3.47M |
| Shares Outstanding (Diluted) | 42.96M | 41.47M | 38.43M | 34.20M | 33.15M | 29.06M | 24.71M | 7.95M | 3.47M |
| EBITDA | -16.56M | -30.87M | -41.50M | -56.16M | -49.58M | -37.44M | -35.23M | -11.24M | -16.34M |
| Gross Margin | 79.57% | 79.03% | 78.78% | 85.24% | 88.43% | 87.87% | 89.91% | 91.27% | 89.35% |
| Operating Margin | -11.11% | -21.08% | -33.79% | -56.02% | -57.31% | -52.55% | -53.50% | -21.61% | -36.16% |
| Net Margin | -9.41% | -18.49% | -31.20% | -57.57% | -62.75% | -59.54% | -57.06% | -31.51% | -48.01% |
This table shows 9 annual periods of SI-BONE's income statement, from FY 2025 back to FY 2017, across 20 line items including revenue, cost of revenue, gross profit. Values in USD; B = billions, M = millions. Fiscal periods follow SIBN's reporting calendar. What is a income statement?